[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US4824839,1989,A
50351-80-9
14165-90-3
89805-39-0
36132-99-7
90047-53-3
847199-06-8
17685-05-1 | Phenyl-beta-d-glucuronide | AA0024WE | MFCD00150627
177332-37-5 | Acridinium, 9-[[4-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]phenoxy]carbonyl]-10-methyl-, 1,1,1-trifluoromethanesulfonate (1:1) | AA00256E | MFCD00797661
177785-14-7 | Methyl 2-(chloromethyl)nicotinate | AA0025GO | MFCD10699438
1781-81-3 | Spiro[5.5]undecan-2-one | AA0025P7 | MFCD00090150
178425-91-7 | β-Alanine, N-(4-methoxyphenyl)- | AA0025YV | MFCD03988000
17882-06-3 | TRIMETHYLSILYL BENZENESULFONATE | AA0026C3 | MFCD00042814
1791-13-5 | H-Asp(OtBu)-OtBu HCl | AA0026PQ | MFCD00034851
1795-15-9 | N-Octylcyclohexane | AA0026ZA | MFCD00039464
179811-63-3 | 2-Amino-2-(3-chlorophenyl)ethanol | AA00277L | MFCD06659478
18344-42-8 | Retinal, 4-hydroxy- | AA0027I6 | MFCD04039566